EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating ...
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary ...
github-actions changed the title azure ai foundry connections should be passed as connection names rather than ID Python: azure ai foundry connections should be passed as connection names rather than ...
Hello guys, I am working on creating a Monitoring using Azure ML mainly for checking the Data Quality signal (Quality of the baseline and production data) and Data Drift signal (Change in distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results